Semaglutide, a GLP-1 drug that slows digestion and curbs appetite, is sold as Wegovy for weight and heart risk and as Ozempic for type 2 diabetes.
Tablet or weekly pen in Denver
Novo announced the Wegovy tablet's approval in December 2025 as the first GLP-1 pill for weight loss [5]. It is swallowed once a day before eating, with 4 ounces of water at most, and food or other pills wait 30 minutes [6]. The pen is a weekly injection. Tablet prices step from $149 (1.5 mg) to $199 (4 mg) to $299 (9 and 25 mg); every standard pen dose is $349 [1]. Details: tablet vs pen.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Denver, from $300 a month.
That box is an ad and says so. It is not a ranking. See how sponsorship works.
Semaglutide prices for Denver
| Product | Monthly cash price | Source |
|---|---|---|
| Wegovy pill, 1.5 mg start | $149 | [1] |
| Wegovy pen, first two fills (0.25 or 0.5 mg) | $199 | [1] |
| Wegovy pen, standard doses | $349 | [1] |
| Ozempic 2 mg | $499 | [7] |
Denver's 65-plus residents and Medicare
Census figures put 12.5% of Denver residents at 65 or older [3]. For Part D members who qualify, the temporary Medicare GLP-1 Bridge pays for Wegovy pens and tablets, Foundayo and the Zepbound KwikPen with a $50 monthly copay until December 31, 2027 [2] [8]. Ozempic is left out [8]. Eligibility turns on BMI plus conditions such as uncontrolled high blood pressure or prediabetes [2].
Colorado Medicaid and private plans
KFF's January 2026 count did not include Colorado among Medicaid programs paying for obesity GLP-1s [4]. Commercial members whose plan covers Wegovy can use Novo's card to pay as little as $25, with savings capped at $100 a month [1]. Denver County's adult obesity rate, 21.6% in 2023, is low for a large city [9]. Nearby, the CU Anschutz Health and Wellness Center in Aurora runs physician-directed weight loss that pairs medication with behavior change and offers self-pay [10]. Read Wegovy and insurance.
Clinic-made semaglutide and license checks
Routine compounded copies of semaglutide lost FDA's 503A allowance on April 24, 2025 [11]. These products have no FDA approval or FDA review, and FDA has reports of hospitalizations after dosing mistakes with compounded injections [12]. The Colorado Medical Board licenses Denver physicians [13]. More: compounded semaglutide and the FDA warning letter tracker.
Regional pages: Salt Lake City semaglutide, Albuquerque, tirzepatide in Denver and Denver weight loss. Background: semaglutide guide.
Check these first
A rodent thyroid C-cell tumor finding gives semaglutide a boxed warning, and it is not for anyone whose own or family history includes MTC or MEN 2 [6]. Nausea hit 44% of people on Wegovy 2.4 mg in trials versus 16% on placebo [6]. Get prompt care for stubborn severe belly pain, allergic signs or very low blood sugar, and call 911 if it is severe. Come off Wegovy at least 2 months ahead of a planned pregnancy [6].
Questions people ask
What does semaglutide cost in Denver with no insurance?
Can Denver Medicare members get Wegovy for $50?
If they qualify. The Medicare GLP-1 Bridge charges a $50 monthly copay for Wegovy from July 1, 2026 to December 31, 2027 [2].
Does Colorado Medicaid cover Wegovy for weight?
No. Colorado was outside the 13 state programs that covered obesity GLP-1s in KFF's January 2026 count [4].
Is there a university weight program near Denver?
Yes. The CU Anschutz Health and Wellness Center in Aurora offers physician-directed weight loss using medications with behavior change, and self-pay is available [10].
What is Denver's adult obesity rate?
CDC PLACES estimates 21.6% for Denver County in 2023; the city and county share one boundary [9].
Who licenses doctors in Denver?
The Colorado Medical Board, within the state's Division of Professions and Occupations [13].
Sources
13 cited
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Weight loss drugs coverage (Medicare GLP-1 Bridge). Medicare.gov (CMS), Oct 17, 2026.
- QuickFacts: Denver city, Colorado. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- Wegovy pill FDA approval for obesity. Novo Nordisk, Dec 22, 2025.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- Ozempic self-pay, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, Oct 17, 2026.
- PLACES county data, 2025 release: Denver County, CO. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- Anschutz Health and Wellness Center. CU Medicine, accessed 2026-10-17.
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. U.S. Food and Drug Administration, Apr 1, 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- Colorado Medical Board. Colorado Division of Professions and Occupations, accessed 2026-10-17.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.